|
|
 |
|
Viewing report
|
|
|
|
Investigator Initiated Trial Management
Cutting Edge Information, Sep 2011, Pages: 111
Life science companies approve and fund investigator initiated trials to meet a number of clinical objectives while building strong relationships with key opinion leaders. The ultimate goal is publication in a medical journal to advance a drug’s - and the company’s - profile and credibility. Supported by dedicated resources, effective IIT teams reach that point by navigating process delays while maintaining regulatory compliance and investigator follow-through at every stage.
Improve IIT management from start to finish using industry benchmarks and best practices. Discover how leading companies streamline processes to make the most of what IITs offer:
- Use internal controls to drive compliance: Establish SOPs that boost efficiency and guarantee accurate documentation of investigator payments. Explore real-world models of IIT management to find out what works and what doesn’t. Know who should be involved, and when, during the four critical IIT stages, and use milestone payments to your advantage.
- Accelerate IIT proposal submission and approval: Simplify IIT applications to minimize errors, and use digital systems to weed out unusable proposals. Align committee review with proposal volume to keep opportunities moving forward. Use timeline benchmarks and trends analysis to set realistic deadlines for proposal submission and approval.
- Win critical resources: Delve into the key drivers of IIT budgets and spending with detailed benchmarks and trends analysis. Gain insights into leading companies’ budgeting protocols and learn executives’ best practices for securing funding.
- Refine corporate strategy: Examine how life sciences companies use IITs to accomplish broader brand and company goals. Identify the top challenges facing IIT teams and learn new strategies for overcoming them.
QUICK SUMMARY
- Report Features
- Table of Contents
- Key Metrics
- Sample Content
- Charts and Graphs
- About CEI
TOTAL NUMBER OF SURVEYED COMPANIES
- 15 Pharmaceutical and Biotech Companies
METRICS AND CHARTS
- 50+ Charts and Graphics
- 400+ Metrics
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
